felin
infecti
periton
viru
fip
viru
fipv
felin
coronaviru
famili
coronavirida
caus
fatal
diseas
call
fip
wild
domest
cat
speci
genom
coronavirus
encod
hydrophob
transmembran
protein
envelop
e
protein
e
protein
possess
ion
channel
activ
viral
protein
ion
channel
activ
collect
term
viroporin
hexamethylen
amilorid
hma
viroporin
inhibitor
inhibit
ion
channel
activ
e
protein
replic
sever
coronavirus
howev
clear
whether
hma
viroporin
inhibitor
affect
replic
fipv
examin
effect
hma
viroporin
inhibitor
did
stilbenedisulphon
acid
amantadin
infect
fipv
serotyp
ii
hma
treatment
drastic
decreas
titer
fipv
serotyp
strain
black
dosedepend
manner
slightli
decreas
titer
fipv
serotyp
ii
strain
contrast
did
treatment
decreas
titer
fipv
serotyp
ii
strain
dosedepend
manner
slightli
decreas
titer
fipv
serotyp
strain
black
investig
whether
differ
ion
channel
activ
e
protein
viral
serotyp
use
e
coli
cell
express
e
protein
fipv
serotyp
ii
differ
observ
suggest
viroporin
e
protein
influenc
differ
action
hma
did
fipv
serotyp
ii
felin
infecti
periton
viru
fip
viru
fipv
felin
coronaviru
fcov
genu
alphacoronaviru
subfamili
coronavirina
caus
fatal
diseas
call
fip
wild
domest
cat
speci
cat
fip
develop
lesion
accompani
necrosi
pyogen
granulomat
inflamm
sever
organ
includ
liver
lung
spleen
central
nervou
system
pleural
periton
effus
also
accumul
cat
fcov
virion
mainli
compos
nucleocapsid
n
envelop
e
membran
peplom
spike
protein
fcov
classifi
serotyp
ii
base
amino
acid
sequenc
protein
serotyp
consist
two
biotyp
fipv
felin
enter
coronaviru
fecv
fecv
infect
asymptomat
cat
howev
fipv
infect
caus
fip
protein
encod
coronaviru
genom
show
ion
channel
activ
exampl
e
protein
sever
acut
respiratori
syndrom
coronaviru
sarscov
protein
human
coronaviru
hcov
report
show
ion
channel
activ
viral
protein
ion
channel
activ
also
report
virus
collect
term
viroporin
involv
viroporin
replic
bud
confirm
influenza
viru
human
immunodefici
viru
hiv
hepat
c
viru
hcv
replic
virus
shown
markedli
inhibit
viroporin
inhibitor
amantadin
acid
did
hexamethylen
amilorid
hma
identifi
viroporin
inhibitor
wilson
et
al
report
hma
inhibitor
e
protein
ion
channel
inhibit
viral
replic
mous
hepat
viru
mhv
antivir
effect
hma
fipv
clarifi
present
studi
examin
effect
hma
viroporin
inhibitor
did
amantadin
infect
fipv
serotyp
ii
inhibitori
effect
hma
did
viral
replic
vari
serotyp
thu
investig
whether
differ
ion
channel
activ
e
protein
fipv
serotyp
ii
employ
simpl
assay
system
use
escherichia
coli
e
coli
express
gst
fusion
protein
cell
macrophagelik
cell
grown
eagl
minimum
essenti
medium
contain
medium
fetal
calf
serum
fc
antibiot
serotyp
fipv
strain
isol
laboratori
serotyp
fipv
black
strain
suppli
dr
j
k
yamamoto
univers
florida
seroyp
ii
fipv
suppli
dr
c
horzinek
state
univers
utrecht
virus
grown
cell
hma
amantadin
did
obtain
sigma
aldrich
usa
compound
store
dimethyl
sulfoxidemethanol
sodium
bicarbon
ethanol
respect
day
experi
compound
dilut
desir
concentr
mainten
medium
cell
viabil
measur
use
assay
describ
previous
briefli
cell
seed
plate
viroporin
inhibitor
ad
triplic
well
hour
cultur
supernat
remov
solut
cell
prolifer
assay
kit
kishida
chemic
co
ltd
japan
ad
cell
return
incub
hour
absorb
formazan
produc
measur
nm
use
spectrophotometr
plate
reader
describ
manufactur
percentag
viabil
calcul
use
follow
formula
cytotox
od
viroporin
inhibitor
solvent
untreat
cell
viroporin
inhibitor
solvent
treat
cell
od
viroporin
inhibitor
solvent
untreat
cell
cc
defin
cytotox
concentr
viroporin
inhibitor
reduc
absorb
treat
cell
compar
cell
control
viru
multipl
infect
moi
ad
cultur
adsorb
cell
hour
wash
cell
cultur
medium
contain
viroporin
inhibitor
cultur
supernat
collect
h
viru
titer
measur
ec
defin
effect
concentr
viroporin
inhibitor
reduc
viru
titer
cultur
supernat
infect
cell
compar
viru
control
result
also
express
use
select
index
si
cc
ec
viru
moi
ad
cultur
adsorb
cell
hour
wash
cell
cultur
mainten
medium
contain
viroporin
inhibitor
carboxymethyl
cellulos
cmcmem
without
carboxymethyl
cellulos
mem
case
cell
cultur
cmcmem
cell
monolay
incub
hour
fix
stain
crystal
violet
solut
contain
buffer
formalin
result
plaqu
count
case
cell
cultur
mem
cultur
supernat
collect
hour
postinfect
viru
titer
determin
tcid
assay
region
encod
e
protein
domain
protein
fipv
serotyp
strain
e
protein
fipv
serotyp
ii
strain
amplifi
rtpcr
use
method
describ
takano
et
al
primer
use
amplifi
region
shown
tabl
pcr
product
insert
pentrdtopo
invitrogen
usa
use
recombin
construct
use
transfect
e
coli
strain
invitrogen
usa
bacteri
cultur
grown
h
od
express
protein
induc
addit
wv
larabinos
sigma
aldrich
usa
normal
gst
e
protein
gst
protein
express
bgalactosidas
assay
perform
use
modif
method
describ
guinea
carrasco
liao
et
al
briefli
variou
time
induct
e
coli
pellet
resuspend
ml
medium
contain
mm
onitrophenylb
galactopyranosid
onpg
sigma
aldrich
usa
incub
minut
sodium
carbon
ad
stop
reaction
reaction
solut
centrifug
supernat
collect
absorb
od
nm
measur
valu
bgalactosidas
activ
normal
total
e
coli
cellular
protein
data
two
group
analyz
student
ttest
multipl
group
analyz
oneway
anova
investig
cytotox
hma
viroporin
inhibitor
viabil
cell
measur
hour
addit
reagent
fig
hma
did
amantadin
exhibit
strong
cytotox
lm
respect
cc
valu
viroporin
inhibitor
shown
tabl
influenc
hma
viroporin
inhibitor
viru
releas
fipvinfect
cell
investig
fig
hma
treatment
drastic
decreas
titer
fipv
serotyp
strain
black
dosedepend
manner
decreas
titer
fipv
serotyp
ii
strain
slightli
contrast
did
treatment
decreas
titer
fipv
serotyp
ii
strain
dosedepend
manner
decreas
titer
fipv
strain
serotyp
black
amantadin
treatment
chang
titer
viral
strain
cultur
supernat
ec
si
valu
viroporin
inhibitor
shown
tabl
evalu
mechan
inhibitori
effect
viroporin
inhibitor
fipv
growth
analyz
growth
kinet
fipv
growth
cell
infect
low
high
moi
wash
treat
cell
viroporin
inhibitor
compar
plaqu
count
cell
viru
titer
cultur
supernat
hma
did
inhibit
plaqu
format
serotyp
low
high
moi
fig
howev
treatment
lm
hma
significantli
decreas
viru
titer
cultur
supernat
cell
infect
fipv
serotyp
moi
treatment
lm
hma
lm
did
also
decreas
viru
titer
cultur
supernat
cell
infect
fipv
serotyp
ii
moi
addit
reduct
plaqu
size
also
influenc
fipv
e
protein
express
growth
membran
permeabl
e
coli
cell
gene
region
encod
e
protein
fipv
serotyp
strain
fipv
serotyp
ii
strain
insert
vector
e
coli
cell
transform
vector
respect
neg
control
gene
region
encod
protein
region
fipv
serotyp
strain
insert
vector
subsequ
introduc
e
coli
cell
express
protein
target
estim
molecular
weight
confirm
hour
protein
induct
transform
e
coli
cell
fig
predict
size
gst
gst
gst
alon
kda
respect
influenc
e
protein
express
growth
e
coli
cell
investig
growth
cell
significantli
lower
hour
cell
induct
gst
e
protein
cell
without
induct
fig
contrast
signific
differ
growth
observ
cell
induct
gst
gst
protein
cell
without
induct
fig
relationship
inhibit
e
coli
cell
growth
eproteinexpressioninduc
chang
membran
permeabl
investig
assess
incorpor
substrat
bgalactosidas
onpg
e
coli
cell
uptak
onpg
cell
significantli
higher
hour
cell
induct
gst
e
protein
cell
without
induct
fig
contrast
signific
chang
observ
uptak
onpg
cell
induct
gst
protein
cell
without
induct
fig
uptak
onpg
significantli
lower
hour
cell
gst
protein
induc
cell
without
induct
fig
viroporin
hydrophob
lowmolecularweight
viral
transmembran
protein
presenc
viroporin
recent
report
mani
virus
function
clarifi
viroporin
form
oligom
make
hydrophil
pore
hostinfect
cell
endosom
membran
pore
shown
transport
substanc
insid
outsid
cell
membran
involv
homeostasi
intracellular
ion
chang
cell
membran
polar
local
intracellular
substanc
bud
releas
viru
particl
liao
et
al
madan
et
al
report
e
protein
sarscov
mhv
belong
genu
betacoronaviru
function
viroporin
function
e
protein
viroporin
also
clarifi
member
genu
alphacoronaviru
recent
report
protein
sarscov
protein
function
viroporin
investig
inhibitori
effect
viroporin
inhibitor
replic
fipv
serotyp
ii
use
cell
inhibitori
effect
viral
replic
investig
measur
viru
titer
cultur
supernat
amantadin
show
inhibitori
effect
viral
replic
wherea
hma
drastic
inhibit
fipv
serotyp
replic
dosedepend
manner
slightli
inhibit
fipv
serotyp
ii
hma
drastic
decreas
titer
fipv
serotyp
strain
black
dosedepend
manner
decreas
titer
fipv
serotyp
ii
strain
slightli
contrast
did
decreas
titer
fipv
serotyp
ii
strain
dosedepend
manner
decreas
titer
fipv
serotyp
strain
black
may
due
differ
ion
channel
activ
viroporin
serotyp
ii
fipv
hma
sodium
channel
blocker
wherea
did
chlorid
channel
blocker
suggest
function
sodium
channel
blocker
domin
viroporin
serotyp
fipv
wherea
function
chlorid
channel
blocker
domin
serotyp
ii
fipv
evalu
mechan
inhibitori
effect
viroporin
inhibitor
fipv
growth
variou
antifipv
agent
identifi
vitro
far
know
experi
perform
use
serotyp
ii
fipv
howev
fcovinfect
cat
field
shown
infect
serotyp
fcov
base
find
agent
exhibit
antivir
effect
serotyp
fipv
necessari
studi
hma
confirm
exhibit
antivir
effect
fipv
serotyp
futur
necessari
administ
hma
cat
infect
fipv
serotyp
develop
fip
investig
whether
hma
allevi
symptom
insert
eproteincod
gene
region
fipv
serotyp
fipv
serotyp
ii
strain
plasmid
subsequ
introduc
e
coli
cell
transfect
use
transfect
function
fipv
e
protein
viroporin
investig
refer
studi
liao
et
al
sinc
e
protein
hydrophob
assum
protein
aggreg
cytoplasm
e
coli
cell
express
cell
membran
avoid
e
protein
aggreg
gst
fusion
protein
prepar
griffin
et
al
melton
et
al
report
express
gsttag
viroporin
influenc
ion
channel
activ
viroporin
e
coli
mammalian
cell
cell
growth
c
influenc
fipv
e
protein
express
membran
permeabl
e
coli
cell
e
coli
cell
induc
black
circl
induc
white
circl
larabinos
cell
collect
indic
time
postinduct
cell
resuspend
onpg
solut
incub
h
incub
bgalactosidas
activ
measur
use
cultur
supernat
bgalactosidas
activ
measur
nm
p
vs
treatment
larabinos
control
p
vs
treatment
larabinos
control
data
repres
three
independ
experi
significantli
inhibit
e
coli
cell
transform
hour
induct
suggest
fipv
e
protein
express
e
coli
cell
surfac
function
viroporin
movement
substanc
bacteri
cell
membran
may
alter
intracellular
substanc
essenti
surviv
e
coli
cell
may
exit
cell
signific
elev
bgalactosidas
activ
level
note
hour
induct
e
coli
cell
transform
respect
fipv
e
protein
assum
express
e
coli
surfac
increas
cell
surfac
permeabl
promot
incorpor
onpg
cell
reaction
intracellular
bgalactosidas
onpg
intracellular
bgalactosidas
may
also
exit
cell
react
extracellular
onpg
phenomena
also
report
e
coli
cell
express
sarscov
e
protein
influenza
viru
protein
find
strongli
suggest
fipv
e
protein
function
viroporin
investig
whether
differ
ion
channel
activ
e
protein
serotyp
use
e
coli
cell
express
e
protein
fipv
serotyp
ii
differ
observ
suggest
fipv
possess
viroporin
e
proteinfor
exampl
protein
similar
protein
sarscov
protein
gene
fipv
encod
three
nonstructur
protein
includ
transmembran
protein
could
potenti
viroporin
fipv
report
import
factor
replic
cell
necessari
investig
gene
encod
viroporin
e
protein
fipv
genom
present
studi
abil
hma
viroporin
inhibitor
did
amantadin
inhibit
replic
fipv
serotyp
ii
examin
inhibitori
effect
hma
did
viral
replic
differ
serotyp
far
know
influenc
differ
viral
serotyp
action
viroporin
inhibitor
previous
report
necessari
express
viroporin
fipv
serotyp
ii
mammalian
cell
oocyt
elucid
function
ion
channel
activ
detail
result
strongli
suggest
viroporin
inhibitor
hma
applic
antivir
agent
fipv
serotyp
antivir
action
combin
hma
possibl
therapeut
agent
fip
need
examin
